NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

qPCR及dPCR器具的全球市場

qPCR and dPCR Instrumentation

出版商 Global Industry Analysts, Inc. 商品編碼 290727
出版日期 內容資訊 英文 410 Pages
商品交期: 最快1-2個工作天內
價格
qPCR及dPCR器具的全球市場 qPCR and dPCR Instrumentation
出版日期: 2021年03月01日內容資訊: 英文 410 Pages
簡介

本報告提供全球qPCR及dPCR設備市場相關調查,彙整市場概要和競爭趨勢,產品概要,各地區的趨勢,及加入此市場的主要企業的簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 聚合酵素鏈鎖反應:基因擴增和定量的重要部分
    • 市場規模
    • 發展中國家巨大發展潛力
    • qPCR為主流技術
    • 研究與檢查:主要的應用市場 其他
  • 促進成長要素,市場趨勢,課題
    • 癌症的發病率,罹患率的上升
    • 醫療費擴大促進需求
    • 分子診斷的進步擴大遺傳基因放大技術的需求
    • 預測的遺傳基因診斷與檢查領域的樂觀預測
    • 遺傳基因疾病,感染疾病的罹患率上升
    • 擴大功能性與引進的技術創新 其他
  • 競爭環境
  • 最終用途市場分析
    • PCR的應用領域
    • 醫療和診斷
    • PCR在感染疾病診斷中的重要作用
    • 抗生素抗藥性的檢測
    • 司法鑑定,親子鑑定實驗
    • 食品安全
    • 與食品病原體的檢測定量化 其他
  • 產品概要
  • 產品技術創新/引進
  • 近幾年的產業活動
  • 主要企業
    • Agilent Technologies, Inc.
    • Becton, Dickinson and Company
    • BioFire Diagnostics, Inc.
    • Bio-Rad Laboratories, Inc.
    • Cepheid
    • Eppendorf AG
    • F. Hoffmann-La Roche Ltd.
    • Fluidigm Corporation
    • Promega Corporation
    • QIAGEN N.V.
    • RainDance Technologies, Inc.
    • TaKaRa BIO株式會社
    • Thermo Fisher Scientific Inc
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 南美

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-7856

Abstract:

Global qPCR and dPCR Instrumentation Market to Reach $9.2 Billion by 2026

Real-Time PCR also referred to as Quantitative PCR (qPCR) analysis, is a modification of the traditional PCR technique. In traditional Polymerase Chain Reaction (PCR), the amplified DNA product or amplicon is detected in an end-point analysis by visualization of the DNA product on an agarose gel subsequent to completion of the reaction, which comprises a specified number of amplification cycles. In real-time PCR, however, the accumulation of amplification product is evaluated simultaneously with the progress of the reaction. Product quantification is carried out in real time, after every cycle. Digital PCR (dPCR) is an improvement of traditional PCR methods and is utilized to directly quantify as well as clonally amplify nucleic acids such as DNA, RNA, cDNA or methylated DNA. However, digital PCR is at an early stage. The main difference between conventional PCR and dPCR lies in the method used to measure amounts of nucleic acids. Sensitivity of dPCR is high in comparison to qPCR, hence, the technology is particularly used in applications wherein there is a low amount of target sequence. For instance, mutation genes that are found on a very low scale in rare diseases, and HIV DNA that are present in 1,000-10,000 in number within the cell of a patient can be easily detected through the technology.

Amid the COVID-19 crisis, the global market for qPCR and dPCR Instrumentation estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2026, growing at a CAGR of 9.8% over the analysis period. qPCR, one of the segments analyzed in the report, is projected to grow at a 9.3% CAGR to reach US$8.4 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the dPCR segment is readjusted to a revised 13% CAGR for the next 7-year period. This segment currently accounts for a 12.5% share of the global qPCR and dPCR Instrumentation market.

The U.S. Market is Estimated at $1.9 Billion in 2021, While China is Forecast to Reach $742.3 Million by 2026

The qPCR and dPCR Instrumentation market in the U.S. is estimated at US$1.9 Billion in the year 2021. The country currently accounts for a 30.8% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$742.3 Million in the year 2026 trailing a CAGR of 12.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR while Rest of European market (as defined in the study) will reach US$813.9 Million by the close of the analysis period.

While Europe is another large market for qPCR and dPCR instrumentation, growth worldwide is projected to be spearheaded by Asia-Pacific. In terms of concentration, a large number of leading companies are located in the US and Europe. However, increasing competition in the markets over the last few years has been driving various players to shift their attention to other promising regions including Latin America and Asia-Pacific. In Asia-Pacific, growth is led by the increased use of qPCR in blood donor testing & screening and diagnosis of infectious diseases and tropical diseases such as Malaria. Increasing geriatric population and the resulting incidents of chronic medical conditions such as cancer coupled with broader application of PCR to study mutations and gene anomalies related to these diseases are driving adoption. Falling cost of nucleic acid detection, quantification, and amplification techniques will additionally encourage adoption of qPCR and dPCR instrumentation in research and diagnosis, particularly in developing, resource poor countries. Asia-Pacific has been witnessing increasing focus of PCR solution suppliers to establish or expand their production and sales network in the region. In the recent years, various vendors have shifted their manufacturing units to the region for enjoying cost benefits and accessing domestic markets, which in turn is increasing awareness of the technology in the region, contributing to growth in the market.

Select Competitors (Total 74 Featured) -

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • BioFire Diagnostics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • Eppendorf AG
  • F. Hoffmann-La Roche Ltd.
  • Fluidigm Corporation
  • Promega Corporation
  • QIAGEN N.V.
  • RainDance Technologies, Inc.
  • Takara Bio, Inc.
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Polymerase Chain Reaction (PCR): An Integral Part of Gene Amplification & Quantification
    • Impact of Covid-19 and a Looming Global Recession
    • 2020 Marked as a Year of Disruption & Transformation
    • EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2019 to 2022
    • Impact of COVID-19 on Clinical Diagnostics Sector
    • Emergence of PCR as a Preferred COVID-19 Detection Method
    • Performance Analysis of COVID-19 Tests
    • EXHIBIT 2: Total Number of COVID-19 Tests Conducted in the Most Impacted Countries: As of January 13th, 2021
    • Molecular Tests (RT-PCR) Occupy a Predominant Share of the COVID-19 Testing Market
    • EXHIBIT 3: Global COVID-19 Testing Market Breakdown by Testing Type: 2020 and 2027
    • Select Approved Covid-19 Molecular Assay Tests
    • Recent PCR Based Tests
    • Digital PCR Sparks Increasing Interest
    • High-Speed NanoPCR Technology Developed for Point-of-Care Diagnosis of COVID-19
    • CRISPR Emerges as Cutting-Edge Biotechnology in COVID-19 Diagnostic Market
    • Demand for PCR Testing to Remain Buoyant in 2021
    • Real-Time PCR and Digital PCR: Scope and Definition
    • Real-Time PCR or Quantitative PCR (qPCR)
    • qPCR Instrumentation
    • Disadvantages
    • Advantages of qPCR
    • End-Use Applications of qPCR
    • Digital PCR (dPCR)
    • Working Principle
    • Applications of dPCR
    • Advantages of dPCR
    • qPCR Remains the Mainstay Technology
    • Digital PCR to Experience Strong Growth
    • High Installation Cost Remains a Roadblock to Widespread Adoption of dPCR
    • Developing Countries Drive Growth Opportunities
    • Competition
    • Competitive Factors
    • Accelerated Commercialization of Products
    • Manufacturers Step-Up Online Exposure
    • Targeted Expansion of Distribution Reach and Global Footprint
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Striking the Right Balance between qPCR and dPCR in Research Laboratories
    • qPCR: A Suitable Tool for Gene Expression and Validation
    • Digital PCR Takes Quantification of Nucleic Acids to the Next Level
    • dPCR: A Valuable Tool in Virology Research
    • Increasing Incidence and Prevalence of Cancer: A Grim Reality Driving Demand for qPCR and dPCR
    • EXHIBIT 4: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • EXHIBIT 5: Breakdown of Total Number of Cancer Cases by Region: 2020
    • EXHIBIT 6: Breakdown of Total Number of Cancer Cases by Type: 2020
    • dPCR for Analyzing Hematologic Malignancies
    • dPCR for Liquid Biopsies
    • Progress in Molecular Diagnostics Spur Demand for the Gene Amplification Technologies
    • Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter
    • EXHIBIT 7: Global Prenatal Diagnostics Market in US$ Billion: 2015 and 2022
    • EXHIBIT 8: Global Genetic Testing Market in US$ Billion: 2020 and 2027
    • Rise in Infectious Diseases Drives Opportunities for Biochips
    • EXHIBIT 9: Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
    • EXHIBIT 10: Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
    • Innovations in Instrumentation Expand Functionality and Drive Adoption
    • Advancements in Probe Technology Enhance qPCR Sensitivity
    • qPCR Market to Witness Increasing Affinity for Automated and Robotic Equipment
    • Lab on Chip/Microfluidic Real-time-PCR
    • Synoptic Review of Quantitative PCR Technical Advancements in the Recent Years
    • ddPCR: The More Advanced Digital Approach to dPCR
    • ddPCR Gains Traction in Cancer Diagnosis
    • Monitoring Disease Progression in HIV Studies
    • EXHIBIT 11: Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
    • Analysis of Genetically Modified Organisms in Edible Products
    • RT-ddPCR Techniques Applied for Quantitating RNA Viruses in Water Samples
    • Technology Advancements Aid in Overcoming Barriers
    • Alternate Technologies Pose Threat to Growth of PCR Market
    • Next-Generation Sequencing to Emerge as Novel Technique in Fight with COVID-19
    • Improving Healthcare Expenditure to Drive Demand for qPCR and dPCR-based Tests
    • EXHIBIT 12: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • PCR in Forensic and Paternity Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for qPCR and dPCR Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for qPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for qPCR by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for dPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for dPCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for dPCR by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Research Laboratories & Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Clinical Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Clinical Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Clinical Research Organizations by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Forensic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 32: World Historic Review for Forensic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: World 15-Year Perspective for Forensic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 34: USA Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 37: USA Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: USA Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: USA 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 40: USA Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: USA Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: USA 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 43: Canada Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Canada 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 46: Canada Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Canada Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Canada 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 49: Canada Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Canada Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Canada 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 52: Japan Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Japan Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Japan 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 55: Japan Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Japan Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Japan 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 58: Japan Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Japan Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Japan 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 61: China Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: China Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: China 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 64: China Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: China Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: China 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 67: China Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: China Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: China 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 70: Europe Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Europe 15-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 73: Europe Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Europe 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 76: Europe Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Europe Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Europe 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 79: Europe Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Europe Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: Europe 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 82: France Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: France Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: France 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 85: France Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: France Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: France 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 88: France Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: France Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: France 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 91: Germany Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Germany Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Germany 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 94: Germany Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Germany Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Germany 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 97: Germany Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Germany Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Germany 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 100: Italy Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Italy Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Italy 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 103: Italy Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Italy Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Italy 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 106: Italy Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: Italy Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Italy 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 109: UK Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: UK Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: UK 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 112: UK Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: UK Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: UK 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 115: UK Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: UK Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: UK 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 118: Spain Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Spain Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Spain 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 121: Spain Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Spain Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Spain 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 124: Spain Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Spain Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Spain 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 127: Russia Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Russia Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Russia 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 130: Russia Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Russia Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Russia 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 133: Russia Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Russia Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Russia 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 136: Rest of Europe Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of Europe 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 139: Rest of Europe Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Rest of Europe 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 142: Rest of Europe Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Rest of Europe 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 145: Asia-Pacific Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 146: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 148: Asia-Pacific Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 151: Asia-Pacific Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 154: Asia-Pacific Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 157: Australia Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Australia Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Australia 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 160: Australia Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Australia Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: Australia 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 163: Australia Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Australia Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: Australia 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 166: India Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: India Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: India 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 169: India Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: India Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: India 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 172: India Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: India Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: India 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 175: South Korea Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: South Korea Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: South Korea 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 178: South Korea Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: South Korea Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: South Korea 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 181: South Korea Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: South Korea Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: South Korea 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 184: Rest of Asia-Pacific Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Rest of Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 187: Rest of Asia-Pacific Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Rest of Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 190: Rest of Asia-Pacific Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Rest of Asia-Pacific 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 193: Latin America Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 194: Latin America Historic Review for qPCR and dPCR Instrumentation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 196: Latin America Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Latin America Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 199: Latin America Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Latin America Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 202: Latin America Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Latin America Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 205: Argentina Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Argentina Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Argentina 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 208: Argentina Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Argentina Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Argentina 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 211: Argentina Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Argentina Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Argentina 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 214: Brazil Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Brazil Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 216: Brazil 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 217: Brazil Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 218: Brazil Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 219: Brazil 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 220: Brazil Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 221: Brazil Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 222: Brazil 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 223: Mexico Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 224: Mexico Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 225: Mexico 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 226: Mexico Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 227: Mexico Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 228: Mexico 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 229: Mexico Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 230: Mexico Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 231: Mexico 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 232: Rest of Latin America Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 233: Rest of Latin America Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 234: Rest of Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 235: Rest of Latin America Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 236: Rest of Latin America Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 237: Rest of Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 238: Rest of Latin America Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 239: Rest of Latin America Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 240: Rest of Latin America 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 241: Middle East Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 242: Middle East Historic Review for qPCR and dPCR Instrumentation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 243: Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 244: Middle East Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 245: Middle East Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 246: Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 247: Middle East Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 248: Middle East Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 249: Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 250: Middle East Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 251: Middle East Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 252: Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 253: Iran Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 254: Iran Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 255: Iran 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 256: Iran Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 257: Iran Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 258: Iran 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 259: Iran Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 260: Iran Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 261: Iran 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 262: Israel Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 263: Israel Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 264: Israel 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 265: Israel Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 266: Israel Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 267: Israel 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 268: Israel Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 269: Israel Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 270: Israel 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 271: Saudi Arabia Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 272: Saudi Arabia Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 273: Saudi Arabia 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 274: Saudi Arabia Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 275: Saudi Arabia Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 276: Saudi Arabia 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 277: Saudi Arabia Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 278: Saudi Arabia Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 279: Saudi Arabia 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 280: UAE Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 281: UAE Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 282: UAE 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 283: UAE Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 284: UAE Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 285: UAE 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 286: UAE Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 287: UAE Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 288: UAE 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 289: Rest of Middle East Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 290: Rest of Middle East Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 291: Rest of Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 292: Rest of Middle East Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 293: Rest of Middle East Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 294: Rest of Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 295: Rest of Middle East Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 296: Rest of Middle East Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 297: Rest of Middle East 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 298: Africa Current & Future Analysis for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 299: Africa Historic Review for qPCR and dPCR Instrumentation by Classification - qPCR and dPCR Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 300: Africa 15-Year Perspective for qPCR and dPCR Instrumentation by Classification - Percentage Breakdown of Value Revenues for qPCR and dPCR for the Years 2012, 2020 & 2027
    • TABLE 301: Africa Current & Future Analysis for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 302: Africa Historic Review for qPCR and dPCR Instrumentation by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 303: Africa 15-Year Perspective for qPCR and dPCR Instrumentation by Component - Percentage Breakdown of Value Revenues for Reagents & Consumables, Instruments and Software & Services for the Years 2012, 2020 & 2027
    • TABLE 304: Africa Current & Future Analysis for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 305: Africa Historic Review for qPCR and dPCR Instrumentation by End-Use - Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 306: Africa 15-Year Perspective for qPCR and dPCR Instrumentation by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Pharma & Biotech Companies, Clinical Research Organizations and Forensic Laboratories for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 74